Stay updated on platform news and potential beta tests.

Regular

Entrepreneur, investor, and former Genzyme executive Jim Geraghty, JD, MS, discusses how biotech companies can overcome the many hurdles faced in developing treatments for rare and serious diseases.

Images from Cure Tuesday Talks - How to Build a Company and Tackle the Toughest Diseases

Cure Tuesday Talks banner image Jim Geraghty 

This exciting initiative is set to make a significant impact on the startup ecosystem, offering valuable opportunities for growth and innovation. 

The Xchange prize for startups is up and running!

Tuesday Talks: How to Build a Company and Tackle the Toughest Diseases

Seema Kumar 

Chair of the Board, Orchard Theraputics & Pieris Pharmaceuticals 